Mirakhur R K, Ferres C J, Lavery T D
Acta Anaesthesiol Scand. 1983 Dec;27(6):451-3. doi: 10.1111/j.1399-6576.1983.tb01985.x.
Plasma cholinesterase levels were measured in 52 patients following administration of pancuronium 1 mg/70 kg (10 patients) and 0.1 mg/kg (10 patients) and vecuronium in doses of 1 mg/70 kg (10 patients), 0.1 mg/kg (10 patients) and 0.2 mg/kg (12 patients). Both doses of pancuronium produced a significant (P less than 0.05 - less than 0.005) reduction in the enzyme levels. Vecuronium in a dose of 1 mg/70 kg was without any significant effects but the two higher doses produced a dose-related reduction of about 8 and 16% in the enzyme levels, respectively, which was statistically significant (P less than 0.05 - less than 0.001).
对52例患者进行了血浆胆碱酯酶水平测定,这些患者分别接受了以下药物:泮库溴铵1mg/70kg(10例患者)、0.1mg/kg(10例患者),以及维库溴铵,剂量分别为1mg/70kg(10例患者)、0.1mg/kg(10例患者)和0.2mg/kg(12例患者)。两种剂量的泮库溴铵均使酶水平显著降低(P<0.05 - <0.005)。1mg/70kg剂量的维库溴铵无显著影响,但两个较高剂量分别使酶水平降低约8%和16%,呈剂量相关性,具有统计学意义(P<0.05 - <0.001)。